Provided by Tiger Fintech (Singapore) Pte. Ltd.

Merck

84.71
+0.60000.71%
Post-market: 84.740.0300+0.04%19:57 EDT
Volume:10.06M
Turnover:851.40M
Market Cap:212.71B
PE:12.31
High:85.22
Open:84.16
Low:83.84
Close:84.11
Loading ...

More Big Tech names report this week amid AI spending spree. Wall Street still wants some to leave their 'comfort zone.'

Dow Jones
·
Yesterday

S&P 500 Posts Weekly Gain, Hits Fresh Highs as Health Care Leads Broad Climb

MT Newswires Live
·
26 Jul

Evaxion to present two-year clinical efficacy data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025

GlobeNewswire
·
25 Jul

Analysts Offer Insights on Healthcare Companies: Icon (ICLR), Merck & Company (MRK) and Thermo Fisher (TMO)

TIPRANKS
·
24 Jul

Roche considering selling drugs directly to US patients, CEO says

Reuters
·
24 Jul

Dow Up 200 Points On Gains For Shares Of Caterpillar, Merck

Dow Jones
·
23 Jul

Merck Maintains Quarterly Dividend at $0.81 Per Share; Payable Oct. 7 to Shareholders of Record on Sept. 15

MT Newswires Live
·
22 Jul

Merck & Co. Inc. Announces $0.81 Dividend Per Share for Fourth Quarter of 2025

Reuters
·
22 Jul

Six of top 20 pharma companies committed to Veeva Vault CRM, says Barclays

TIPRANKS
·
22 Jul

Looking for Cheap Stocks? Healthcare Shares Haven't Looked This Good in 30 Years. -- Barrons.com

Dow Jones
·
22 Jul

Oppenheimer sees Merck agreement as strong endorsement for Veeva’s Vault CRM

TIPRANKS
·
21 Jul

Merck & Company: Buy Rating Backed by Growth Prospects in Cardiopulmonary and Infectious Disease Franchises

TIPRANKS
·
21 Jul

Health Canada Approves Merck's KEYTRUDA® in Combination with Chemoradiotherapy for Advanced Cervical Cancer

Reuters
·
21 Jul

Merck Commits to Veeva Vault CRM for Major Launch Expansion

Reuters
·
21 Jul

This Healthcare Stock's Revolutionary Drug Could Make Early Investors Rich

Motley Fool
·
21 Jul

3 Monster Stocks in the Making to Buy Right Now

Motley Fool
·
21 Jul

Does This Move Make Merck Stock a Buy?

Motley Fool
·
20 Jul

Should You Forget Pfizer and Buy This Magnificent Dividend Stock Instead?

Motley Fool
·
20 Jul

3M, American Express Share Losses Contribute To Dow's Nearly 250-Point Fall

Dow Jones
·
19 Jul

Merck & Co. Hold Rating: Balancing Promising HIV Pipeline with Competitive Challenges and Market Uncertainty

TIPRANKS
·
18 Jul